Scientists at the University of Minnesota have created a blood vessel replacement that is composed of biological materials but does not have living cells at implantation. Rather, the replacement becomes repopulated with cells by the recipient’s own cells once implanted. This ground-breaking creation could benefit not only dialysis patients, but also those with coronary issues.
This graft has only been used in nonhuman primates thus far, but studies show its promise. No calcification was observed, nor loss of burst strength, nor outflow stenosis, which are all common in other graft options. With the massive amount of people being treating with hemodialysis, this new graft option presents less complications and a potentially higher rate of success. To read more about the progress scientists have made with this new graft, the full study is available in Science Translational Medicine.
Let’s talk DialyGuard!
Talk with one of our experts to get your questions answered and see how we can help you solve your meter and solution pain points.